52-Week Performance Chart

Powered by FactSet Research Systems Inc

Recent Company News

More

Powered by FactSet Research Systems Inc.

Capital Raising Events

More
DR Price Date DR Price (USD) US/Non-US/Total DRS US/Non-US/Total DR Capital Raised
Nov 16, 2006 16.00 14,300,000
0
14,300,000 		228,800,000
0
228,800,000
Apr 24, 2001 10.04 13,225,000
0
13,225,000 		132,779,000
0
132,779,000

No DR Events are available.

No DR Events are available.

Data provided by Thomson Reuters

Institutional Ownership

More
TOP INSTITUTIONAL HOLDERS POSITION
Robeco Institutional Asset Management BV 10,711,236
RBC Global Asset Management (UK) Ltd. 10,029,940
Renaissance Technologies LLC 9,418,428
TOP MUTUAL FUND HOLDERS POSITION
RBC Emerging Markets Equity Fund 5,881,365
St. James's Place Unit Trust - Emerging Markets Equity 4,346,510
Robeco Capital Gr. Fds. - QI Emerging Conservative Equities 2,394,457

Data provided by FactSet Research Systems Inc.

DR Details

DR Symbol RDY
CUSIP 256135203
DR Venue New York Stock Exchange
DR ISIN US2561352038
Ratio DR:ORD 1:1
Underlying ISIN INE089A01023
Country India
Effective Date Apr 24, 2001
Depositary JPMC (Sponsored)
Industry Pharma. & Biotech.
Dr. Reddy's Laboratories is a pharmaceutical company. The Company's segments include: Global Generics, which includes its business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics); Pharmaceutical Services and Active Ingredients, which includes its business of manufacturing and marketing active pharmaceutical ingredients and intermediates; and Proprietary Products, which includes its business that focuses on the research and development of differentiated formulations.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Annual Depositary Service up to $0.0000
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Apr.25 13.92 56,498,509 2,690,405
Mar.25 13.19 38,905,405 1,852,638
Feb.25 12.78 36,821,094 1,937,952

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

Data provided by Thomson Reuters, Inc.

BNY.COM TERMS OF USE PRIVACY POLICY

© 2025 The Bank of New York Mellon Corporation. Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Quotes delayed at least 15 minutes. Market data provided by ICE Data Services. ICE Limitations.
News provided by Comtex News Network and MarketWatch. Powered and implemented by FactSet. Legal Statement.

Certain information included in this website is proprietary to Mergent, Inc. (Mergent) Copyright © 2003-2025. Reproduction of such information in any form is prohibited. Because of the possibility of human or mechanical error by Mergent's sources, Mergent or others, Mergent does not guarantee the accuracy, adequacy, completeness, timeliness or availability or for the results obtained from the use of such information. Mergent Terms of Use apply

Holdings information provided by FactSet Research Systems Inc. Copyright © 2003-2025 FactSet Research Systems Inc. All rights reserved.

Thomson Reuters Marks: The THOMSON REUTERS Kinesis Logo depicted below and THOMSON REUTERS

Redistributor shall display or print the Thomson Reuters Trademarks when Redistributor's Customers are given access to the Services.

Where Redistributor makes available on display any and all Thomson Reuters Marks attributable to the Services, Redistributor shall include the following language in the Help About section or in a general attribution page: "The THOMSON REUTERS Kinesis Logo and THOMSON REUTERS are trademarks of Thomson Reuters and its affiliated companies in the United States and other countries and used herein under license."

Additional Attribution Guidelines by Thomson Reuters: Redistributor shall display or print the following notice in the Help About section or in a general attribution page. "Copyright ©, Thomson Reuters, 1999-2025. All Rights Reserved. Use, duplication, or sale of this service, or data contained herein, except as described in the [Authorized Products name] Subscription Agreement, is strictly prohibited."

THOMSON REUTERS